Evidence map›Paper›PMID 42666616›Full record

ArticleCureus2026

Phlegmonous Gastritis During Consolidation Therapy With High-Dose Cytarabine and FLT3 Inhibitor in FLT3-ITD-Mutated Acute Myeloid Leukemia.

Hidekazu Itamura, Tatsuya Mihashi, Yusuke Hirano, Shinya Kimura

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hidekazu ItamuraDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, JPN.
Tatsuya MihashiDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, JPN.
Yusuke HiranoDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, JPN.
Shinya KimuraDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phlegmonous gastritis (PG) is a rare disorder in which a bacterial infection arises in the gastric wall. We report a patient in his 60s with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)-mutated acute myeloid leukemia (AML) who developed PG during the consolidation therapy with high-dose cytarabine and the FLT3 inhibitor quizartinib. The patient developed fever, abdominal pain, hematemesis, and hypovolemic shock during neutropenia on day 17. Contrast-enhanced computed tomography (CT) showed edematous thickening of the gastric wall with perigastric fat stranding. Upper gastrointestinal endoscopy revealed diffuse edematous mucosa with erosions, and a gastric biopsy culture yielded

Indexed as

acute myeloid leukemia (aml)acute phlegmonous gastritisenterococcus faeciumflt3-inhibitorvonoprazan

Identifiers

PMID42666616
PMCPMC13523538

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.